ABO Blood Type Linked to Heart Bypass Surgery Outcomes
A new study reveals that blood type may influence long-term mortality and bleeding risk in adults after heart bypass surgery.
Updated on Oct. 28, 2026 in Heart Disease
Live Poll
Does learning about blood-type-related health risks change how you view your personal medical outlook?
A recent study suggests that a patient's ABO blood type may influence outcomes following coronary artery bypass grafting (CABG) surgery. Findings indicate distinct differences in postoperative bleeding risk and long-term mortality rates based on blood-group phenotypes.
Why it matters
Understanding how biological traits like blood type influence surgical outcomes helps clinicians better assess individual risk profiles before cardiac procedures. This data provides a new perspective on long-term health monitoring for patients following heart surgery.
This retrospective cohort study followed 2,836 patients for a median of 7.8 years to analyze how ABO blood types affect post-surgical outcomes. Findings showed blood group A had an adjusted hazard ratio of 1.50 for mortality and 0.64 for 30-day bleeding compared to the reference group O.
The players
Kaplan Medical Center
A medical institution that provided ethical oversight for the study.
The details
Researchers utilized multivariable Cox regression and time-to-event methods to correlate blood-group phenotypes with surgical recovery. Patients with blood group O experienced higher rates of 30-day postoperative bleeding, while those with non-O types showed lower bleeding risks. Conversely, blood group A was associated with a higher adjusted hazard ratio for long-term all-cause mortality over the nearly eight-year follow-up period.
Timeline
Patients underwent isolated coronary artery bypass grafting between 2010 and 2025.
The research findings were published in 2026.
Health Landscape
Cardiac surgery outcomes are typically predicted using established risk scores that account for age, comorbidities, and cardiac function. This research challenges the current landscape by demonstrating that ABO blood group phenotypes serve as a significant biological variable in surgical recovery.
Patients preparing for coronary artery bypass grafting may find it useful to discuss their blood type with their surgical team during preoperative planning. While this study adds to our understanding of surgical risk, it should not change your current care plan without physician guidance.
The takeaway
Blood type may act as a silent variable in cardiac surgery recovery, influencing both short-term bleeding risk and long-term health outcomes. If you have a history of heart disease, consider asking your cardiologist about the specific risk factors that apply to your medical profile.
Further reading
For more information on managing your cardiac health, visit our Heart Disease section.
Source note: This article includes information reported by Nature.
Live Poll
Does learning about blood-type-related health risks change how you view your personal medical outlook?
